化合物XMU-MP-1 T4212
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 2061980-01-4 | ¥1,580.00 | 询底价 |
10 mg | 2061980-01-4 | ¥2,960.00 | 询底价 |
1 mg | 2061980-01-4 | ¥589.00 | 询底价 |
5 mg | 2061980-01-4 | ¥1,670.00 | 询底价 |
50 mg | 2061980-01-4 | ¥6,990.00 | 询底价 |
25 mg | 2061980-01-4 | ¥4,880.00 | 询底价 |
100 mg | 2061980-01-4 | ¥9,430.00 | 询底价 |
2 mg | 2061980-01-4 | ¥861.00 | 询底价 |
Product Introduction
Bioactivity
英文名: XMU-MP-1
描述: XMU-MP-1 是一种促凋亡、无菌的 20 样激酶 MST1 和 2 的抑制剂。
激酶实验: XMU-MP-1 is dissolved in DMSO (stock concentration, 10 mM). For the in vitro kinase inhibition assays, recombinant GST-tagged MOB1a and various forms of recombinant His-tagged full-length MST1 or MST2 kinase are expressed and purified from Escherichia coli. The assays are performed with the various doses of XMU-MP-1 in the kinase assay buffer for 30 min at 30°C[1].
体外活性: XMU-MP-1 reduces the phosphorylation of endogenous MOB1, LATS1/2, and YAP in HepG2 cells in a dose-dependent manner at concentrations ranging from 0.1 to 10 μM. XMU-MP-1 treatment inhibits hydrogen peroxide-stimulated MOB1 phosphorylation and MST1/2 autophosphorylation in a variety of cell lines, including mouse macrophage-like cells, human osteosarcoma, human colorectal adenocarcinoma cells. XMU-MP-1 blocks MST1/2 kinase activities, thereby activating the downstream effector Yes-associated protein and promoting cell growth. XMU-MP-1 can potently and reversibly suppress the activities of kinases MST1/2 and enhance their downstream YAP activation in cells.
体内活性: XMU-MP-1 displays excellent in in vivo pharmacokinetics and is able to augment mouse intestinal repair, as well as liver repair and regeneration, in both acute and chronic liver injury mouse models at a dose of 1 to 3 mg/kg via intraperitoneal injection. XMU-MP-1 treatment exhibited substantially greater repopulation rate of human hepatocytes in the Fah-deficient mouse model than in the vehicle-treated control, indicating that XMU-MP-1 treatment might facilitate human liver regeneration. Thus, the pharmacological modulation of MST1/2 kinase activities provides a novel approach to potentiate tissue repair and regeneration, with XMU-MP-1 as the first lead for the development of targeted regenerative therapeutics.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 12.5 mg/mL (30.01 mM)
关键字: XMU MP 1 | Inhibitor | Hippo (MST) | inhibit | XMUMP1 | XMU-MP-1
相关产品: I3MT-3 | Cerdulatinib hydrochloride | IHMT-MST1-58 | Pim1/AKK1-IN-1
相关库: Anti-Aging Compound Library | Anti-Prostate Cancer Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Kinase Inhibitor Library | Stem Cell Differentiation Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物XMU-MP-1 T4212信息由TargetMol中国为您提供,如您想了解更多关于化合物XMU-MP-1 T4212报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途